NO20075671L - Neurodegenerative markorer for psykiatriske tilstander - Google Patents

Neurodegenerative markorer for psykiatriske tilstander

Info

Publication number
NO20075671L
NO20075671L NO20075671A NO20075671A NO20075671L NO 20075671 L NO20075671 L NO 20075671L NO 20075671 A NO20075671 A NO 20075671A NO 20075671 A NO20075671 A NO 20075671A NO 20075671 L NO20075671 L NO 20075671L
Authority
NO
Norway
Prior art keywords
psychiatric conditions
markers
neurodegenerative
disease
values
Prior art date
Application number
NO20075671A
Other languages
English (en)
Norwegian (no)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
Harald Hampel
Norbert Mueller
Original Assignee
Klinik Und Poliklinik Fuer Psy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinik Und Poliklinik Fuer Psy filed Critical Klinik Und Poliklinik Fuer Psy
Publication of NO20075671L publication Critical patent/NO20075671L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
NO20075671A 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander NO20075671L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
PCT/EP2006/002907 WO2006105907A1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for psychiatric conditions

Publications (1)

Publication Number Publication Date
NO20075671L true NO20075671L (no) 2007-11-06

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20075671A NO20075671L (no) 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Country Status (13)

Country Link
US (2) US20080131921A1 (da)
EP (2) EP1866650B1 (da)
JP (1) JP4958893B2 (da)
AT (2) ATE534038T1 (da)
CY (1) CY1110116T1 (da)
DE (1) DE602006014379D1 (da)
DK (2) DK1866650T3 (da)
ES (2) ES2346467T3 (da)
NO (2) NO20075671L (da)
PL (2) PL2146209T3 (da)
PT (2) PT1866650E (da)
SI (1) SI1866650T1 (da)
WO (1) WO2006105907A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5856364B2 (ja) * 2006-08-04 2016-02-09 味の素株式会社 抑うつ病の評価方法、抑うつ病評価装置、抑うつ病評価方法、抑うつ病評価システム、抑うつ病評価プログラム、記録媒体および端末装置
AT9843U1 (de) 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
JP5410997B2 (ja) * 2008-01-31 2014-02-05 則行 川村 うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
JPWO2011019072A1 (ja) 2009-08-12 2013-01-17 ヒューマン・メタボローム・テクノロジーズ株式会社 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
DK2778233T3 (da) 2011-11-10 2017-03-20 Human Metabolome Tech Inc Fremgangsmåde til måling af ethanolaminphosphat
EA201590024A1 (ru) 2012-06-15 2015-05-29 Гарри Стилли Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
WO2014068144A1 (en) 2012-11-05 2014-05-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
EP4428251A3 (en) 2014-09-11 2024-12-18 Immunis.AI, Inc. Methods of detecting prostate cancer
WO2017185085A1 (en) * 2016-04-22 2017-10-26 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
US11079329B2 (en) * 2017-09-27 2021-08-03 University of North Carolina Wilmington Human waste water and human-derived pathogen scouting tool
US20210041460A1 (en) * 2018-03-19 2021-02-11 Fujifilm Wako Pure Chemical Corporation Method for judging psychiatric disorder
WO2019182003A1 (ja) * 2018-03-22 2019-09-26 株式会社日本医療機器技研 生体吸収性ステント
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
WO2021106724A1 (ja) * 2019-11-26 2021-06-03 京セラ株式会社 ストレス計測システムおよびストレス計測方法
WO2022075354A1 (en) * 2020-10-06 2022-04-14 Okinawa Institute Of Science And Technology School Corporation A method for obtaining an index for the diagnosis of alzheimer's disease (ad)
WO2024253194A1 (ja) * 2023-06-08 2024-12-12 東洋紡株式会社 脳機能レベルの層別化を支援するための方法、層別化装置、及び層別化プログラム
CN118566488B (zh) * 2024-04-10 2026-02-27 合肥歆智医疗器械有限公司 抑郁症检测用试剂组合、制造方法、检测系统及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
JP4958893B2 (ja) 2012-06-20
PT1866650E (pt) 2010-06-01
SI1866650T1 (sl) 2010-12-31
EP2146209B1 (en) 2011-11-16
EP1866650B1 (en) 2010-05-19
PL2146209T3 (pl) 2012-05-31
ES2346467T3 (es) 2010-10-15
WO2006105907A1 (en) 2006-10-12
ATE468537T1 (de) 2010-06-15
DK2146209T3 (da) 2012-02-13
PT2146209E (pt) 2011-12-30
ATE534038T1 (de) 2011-12-15
US20120196300A1 (en) 2012-08-02
HK1137219A1 (en) 2010-07-23
DE602006014379D1 (de) 2010-07-01
NO20120452L (no) 2007-11-06
PL1866650T3 (pl) 2011-04-29
CY1110116T1 (el) 2015-01-14
EP1866650A1 (en) 2007-12-19
DK1866650T3 (da) 2010-09-06
US20080131921A1 (en) 2008-06-05
EP2146209A1 (en) 2010-01-20
JP2008537111A (ja) 2008-09-11
ES2377704T3 (es) 2012-03-30

Similar Documents

Publication Publication Date Title
DK2146209T3 (da) Neurodegenerative markører for Alzheimer's sygdom
SI1945622T1 (sl) Izotopično markirane spojine benzfurana kot označevalne snovi za amiloidogenske proteine
WO2005047484A3 (en) Biomarkers for alzheimer's disease
GB0512401D0 (en) Method
EP1872705A4 (en) ENDOSCOPIC PROOF DEVICE
EP1956962A4 (en) METHOD FOR DETERMINING THE FORM OF A BENDABLE INSTRUMENT
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
ATE495167T1 (de) Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
DE602004006664D1 (de) Vorrichtung zum Feststellen der Verschlechterung eines Sauerstoffkonzentrationsensors
DK1330656T3 (da) Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
EP1855525A4 (en) FISH MODELS ZEBRA OF ALZHEIMER'S DISEASE
FR2890446B1 (fr) Methode de detection d'interaction intracellulaire entre bio-molecules
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
EP1856526A4 (en) THIOREDOXIN-INTERACTING PROTEIN (TXNIP) AS REGULATOR OF VASCULAR FUNCTION
UA93870C2 (ru) Меченные радиоактивным галогеном производные фенилоксианилина
NO20030216L (no) Fremgangsmåte for å detektere patogene prionproteiner ved hjelp av massespektroskopi
DK1747465T3 (da) Anvendelse af hidtil ukendte biomarkører til detektion af testikelcarcinom in situ og afledte cancere i humane prøver
WO2005116659A3 (en) Compositions and methods relating to alzheimer’s disease
ATE408827T1 (de) Quantifizierung von stressbelastung
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
ATE442084T1 (de) Messung des energieverbrauchs
EP1907838A4 (en) FRAGMENT OF THE NEUROSCRETOR PROTEIN VGF AS BIOMARKER FOR MORBUS ALZHEIMER

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application